Handelsbanken Fonder’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-53,800
| Closed | -$202K | – | 1574 |
|
|
2024
Q1 | $202K | Hold |
53,800
| – | – | ﹤0.01% | 1509 |
|
|
2023
Q4 | $528K | Buy |
53,800
+17,700
| +49% | +$174K | ﹤0.01% | 1119 |
|
|
2023
Q3 | $301K | Hold |
36,100
| – | – | ﹤0.01% | 1306 |
|
|
2023
Q2 | $480K | Hold |
36,100
| – | – | ﹤0.01% | 1083 |
|
|
2023
Q1 | $418K | Hold |
36,100
| – | – | ﹤0.01% | 1090 |
|
|
2022
Q4 | $295K | Hold |
36,100
| – | – | ﹤0.01% | 1254 |
|
|
2022
Q3 | $210K | Hold |
36,100
| – | – | ﹤0.01% | 1421 |
|
|
2022
Q2 | $160K | Buy |
36,100
+6,700
| +23% | +$29.7K | ﹤0.01% | 1529 |
|
|
2022
Q1 | $268K | Sell |
29,400
-10,900
| -27% | -$99.4K | ﹤0.01% | 1560 |
|
|
2021
Q4 | $825K | Buy |
40,300
+1,300
| +3% | +$26.6K | ﹤0.01% | 998 |
|
|
2021
Q3 | $996K | Hold |
39,000
| – | – | 0.01% | 905 |
|
|
2021
Q2 | $1.36M | Buy |
39,000
+9,800
| +34% | +$343K | 0.01% | 763 |
|
|
2021
Q1 | $973K | Sell |
29,200
-6,300
| -18% | -$210K | 0.01% | 856 |
|
|
2020
Q4 | $921K | Buy |
+35,500
| New | +$921K | 0.01% | 864 |
|